97 related articles for article (PubMed ID: 27344782)
1. [Trends and future of external radiotherapy for prostate cancer].
Nakamura K; Konishi K; Kosugi T
Nihon Rinsho; 2016 May; 74 Suppl 3():499-502. PubMed ID: 27344782
[No Abstract] [Full Text] [Related]
2. A question-filled future for dose escalation in prostate cancer.
Hanks GE
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):267-9. PubMed ID: 7721628
[No Abstract] [Full Text] [Related]
3. Radiotherapy of prostate cancer.
Khoo V
Eur J Cancer; 2011 Sep; 47 Suppl 3():S298-301. PubMed ID: 21943990
[No Abstract] [Full Text] [Related]
4. [History of radiation oncology and present state].
Inokuchi H; Hiraoka M
Nihon Rinsho; 2016 May; 74 Suppl 3():494-8. PubMed ID: 27344781
[No Abstract] [Full Text] [Related]
5. Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy.
Aneja S; Yu JB
Semin Radiat Oncol; 2014 Jan; 24(1):35-42. PubMed ID: 24314340
[TBL] [Abstract][Full Text] [Related]
6. Power against prostate cancer. Intensity-modulated radiation therapy and interstitial brachytherapy.
Cash JC
Adv Nurse Pract; 2006 Sep; 14(9):37-42. PubMed ID: 16972442
[No Abstract] [Full Text] [Related]
7. ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
Michalski JM; Roach M; Merrick G; Anscher MS; Beyer DC; Lawton CA; Lee WR; Pollack A; Rosenthal SA; Vijayakumar S; Carroll PR
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):667-72. PubMed ID: 19386445
[No Abstract] [Full Text] [Related]
8. Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy.
Kupelian P; Willoughby T; Mahadevan A; Djemil T; Weinstein G; Jani S; Enke C; Solberg T; Flores N; Liu D; Beyer D; Levine L
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1088-98. PubMed ID: 17187940
[TBL] [Abstract][Full Text] [Related]
9. Range, range modulation, and field radius requirements for proton therapy of prostate cancer.
Moyers MF; Miller DW
Technol Cancer Res Treat; 2003 Oct; 2(5):445-7. PubMed ID: 14529309
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of prostate cancer in radiation oncology: what radiologists need to know.
Boonsirikamchai P; Choi S; Frank SJ; Ma J; Elsayes KM; Kaur H; Choi H
Radiographics; 2013 May; 33(3):741-61. PubMed ID: 23674772
[TBL] [Abstract][Full Text] [Related]
11. Reduction of treatment volume and radiation doses to surrounding tissues with intraprostatic gold markers in prostate cancer radiotherapy.
Langenhuijsen JF; Smeenk RJ; Louwe RJ; van Kollenburg P; Kaanders JH; Witjes JA; van Lin EN
Clin Genitourin Cancer; 2011 Dec; 9(2):109-14. PubMed ID: 21903486
[TBL] [Abstract][Full Text] [Related]
12. Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinoma.
Hayden AJ; Martin JM; Kneebone AB; Lehman M; Wiltshire KL; Skala M; Christie D; Vial P; McDowall R; Tai KH;
J Med Imaging Radiat Oncol; 2010 Dec; 54(6):513-25. PubMed ID: 21199428
[TBL] [Abstract][Full Text] [Related]
13. Prostate tumor alignment and continuous, real-time adaptive radiation therapy using electromagnetic fiducials: clinical and cost-utility analyses.
Quigley MM; Mate TP; Sylvester JE
Urol Oncol; 2009; 27(5):473-82. PubMed ID: 18625565
[TBL] [Abstract][Full Text] [Related]
14. A novel method for comparing 3D target volume delineations in radiotherapy.
van der Put RW; Raaymakers BW; Kerkhof EM; van Vulpen M; Lagendijk JJ
Phys Med Biol; 2008 Apr; 53(8):2149-59. PubMed ID: 18379021
[TBL] [Abstract][Full Text] [Related]
15. Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer.
O'Donnell HE; Finnegan K; Eliades H; Oliveros S; Plowman PN
Br J Radiol; 2008 Apr; 81(964):327-32. PubMed ID: 18344276
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee.
Buyyounouski MK; Price RA; Harris EE; Miller R; Tomé W; Schefter T; Parsai EI; Konski AA; Wallner PE
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1297-304. PubMed ID: 20338473
[No Abstract] [Full Text] [Related]
17. Choosing wisely.
Lawton C
Pract Radiat Oncol; 2014; 4(6):356-7. PubMed ID: 25407854
[No Abstract] [Full Text] [Related]
18. Long-term follow-up of radiotherapy for prostate cancer.
Pisansky TM
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1663-4; author repply 1664. PubMed ID: 15590203
[No Abstract] [Full Text] [Related]
19. Combined hormone therapy and radiation therapy for locally advanced prostate cancer.
Bolla M; Laramas M;
Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e30-4. PubMed ID: 21144766
[TBL] [Abstract][Full Text] [Related]
20. RTOG clinical trials for prostate cancer.
DeMare PA
Hawaii Med J; 2007 Oct; 66(10):273-4, 276. PubMed ID: 18065125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
